Navigation Links
Optimer Pharmaceuticals Announces Key Additions to Management Team
Date:1/10/2011

r holds a Ph.D. in philosophy, health administration from Columbia Southern, a Master of Public Administration with a specialization in health care from C.W. Post College, and a B.S. in, medical biology also from C.W. Post College.

Hemal Shah has spent more than 10 years in HEOR at Boehringer Ingelheim Pharmaceuticals, most recently as Executive Director, where she was focused on the hospital market for the launch of Spivira® for a chronic obstructive pulmonary disease.  She held positions of increasing responsibility in HEOR, implementing HEOR tools including medication adherence, healthcare reforms, health related quality of life research, health economic model development, and pharmacoeconomic analyses to support arguments for commercialization. Shah received her Doctor of Pharmacy from Rutgers State University and holds a B.S. from the University of Connecticut.

Dr. Womelsdorf has more than 15 years of experience in business development roles at Cyclacel Pharmaceuticals, Johnson & Johnson (J&J), F. Hoffmann-La Roche, Baxter International and, most recently, with his own consulting firm.  As the Vice President, Business Development at Cyclacel, he was responsible for all aspects of corporate and business development and licensing including the repositioning of key programs. During his tenure at J&J, Dr. Womelsdorf closed multiple transactions, including a deal with MGI Pharma that gave J&J rights outside North America to Dacogen™ (decitabine), a late stage oncology product with utility in Myelodysplastic Syndromes, Acute Myeloid Leukemia and other cancers. He was appointed to the Board of Tibotec Therapeutics, J&J's oncology and virology company, where he helped oversee the transition of the Company to a commercial entity culminating in the successful launch of Prezista™ (darunivir), a novel protease inhibitor for the treatment of HIV. Prior to joining J&J, he worked as a Global Licensing Director f
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Optimer Pharmaceuticals Obtains Additional Fidaxomicin Patent
2. Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection
3. Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations
4. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
5. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
6. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
7. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
8. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
9. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
11. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... to release its financial results for the fiscal 2014 ... market trading ends on Tuesday, September 9, 2014. ... 4:30 p.m. U.S. EDT on Tuesday, September 9, 2014 ... the Company,s financial results, commercial partnerships, and future outlook.  ...
(Date:8/29/2014)... UNION CITY, Calif. , Aug. 29, 2014 /PRNewswire/ ... products company manufacturing point-of-care blood instrumentation and consumables to ... Clint Severson , Chairman and Chief Executive Officer, ... Annual Best Ideas Conference 2014 on Tuesday, September 9, ... held at the Omni Berkshire Place Hotel in ...
(Date:8/29/2014)... -- Research and Markets  has announced the addition ... Market 2014-2018" report to their offering. ... that connect, support, or surround bones. There are several ... cartilage, fascia, and other fibrous tissues. Repetitive use, accidents, ... result in wear and tear in these tissues. Orthopedic ...
Breaking Medicine Technology:Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3
(Date:8/30/2014)... 30, 2014 Hundreds of Byetta lawsuits ... to move forward in U.S. courts, Bernstein Liebhard LLP ... on July 31, 2014, Byetta and Bydureon (an extended-release ... liability claims that allege the drugs caused pancreatitis, pancreatic ... of these claims are pending in a multidistrict litigation ...
(Date:8/30/2014)... Springs, CO (PRWEB) August 30, 2014 In ... and increasingly difficult to get. Snoring and sleep apnea (a ... stops) rob people and their bed partners of the rest ... to 45% of the population snores and 20 million people ... only 10% have been diagnosed and treated; and of those ...
(Date:8/30/2014)... 2014 Market Research Report on ... a professional and in-depth market survey on Global ... reviews the basic information of Lab Oven including ... then explores global and China’s top manufacturers of ... value, and market share etc. , The report ...
(Date:8/30/2014)... 30, 2014 The federal judge ... ( http://www.injurybeacon.com/transvaginal-mesh/ ) filed against Boston Scientific Corp. ... cases selected for one of the proceeding’s bellwether ... 18, 2014, U.S. District Judge Joseph R. Goodwin ... with Boston Scientific’s contention that a consolidated trial ...
(Date:8/30/2014)... 30, 2014 In today’s world, a ... difficult to get. Snoring and sleep apnea (a medical ... stops) robs people and their bed partners of the ... to 45% of the population snores and 20 million ... Of these, only 10% have been diagnosed and treated; ...
Breaking Medicine News(10 mins):Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... knowledge about appetite regulation among people , , MONDAY, Dec. 15 ... be obese, based on the discovery of six additional genetic ... new study says. , The study by an ... , adds to previous research that linked two other genetic ...
... efficacy of The Pink Patch for weight control with ... in 4 weeks. The Pink Patch is a once-a-day ... loss goals. Dr. Hudson stated in her findings, ... dietary or activity changes, The Pink Patch, can potentially ...
... 15 The Endovascular Forum, Inc. (EVF), an ... Cardiovascular Angiography,and Interventions (SCAI), announced a collaboration to ... complex clinical skills,development in Cardiovascular medicine. The partnership ... developing a new generation of tools for,physicians to ...
... will provide an integrated approach to home-based care and support. , ... The launch of a new company aimed at promoting and supporting ... is introducing new programs and innovating existing services to help individuals ... , "Due to falling birthrates and increased life expectancy, ...
... American Chemical Society (ACS) News Service Weekly PressPac with ... & Engineering News .Please credit the individual journal or ... information. , , News Items in This Edition:, , ... countries outside U.S., Advance in the battle against "gray ...
... Achievements of Past Century Include Major Milestones in the Advancement ... , , ALEXANDRIA, Va., Dec. ... its Centennial Year: "Celebrating the Legacy, Forging the Future." ... story of one person who turned a personal struggle with ...
Cached Medicine News:Health News:Genetic Variants Tied to Obesity 2Health News:Double Blind Study Proves The Pink Patch Works for Weight Loss 2Health News:Double Blind Study Proves The Pink Patch Works for Weight Loss 3Health News:The Endovascular Forum, Inc. and the Society for Cardiovascular Angiography and Interventions Partner to Extend the Influence of Electronic Medical Care Innovation to Cardiovascular Medicine Through www.EndoVascular.Org, a Global, Multi-disciplinary Care 2Health News:The Endovascular Forum, Inc. and the Society for Cardiovascular Angiography and Interventions Partner to Extend the Influence of Electronic Medical Care Innovation to Cardiovascular Medicine Through www.EndoVascular.Org, a Global, Multi-disciplinary Care 3Health News:The Endovascular Forum, Inc. and the Society for Cardiovascular Angiography and Interventions Partner to Extend the Influence of Electronic Medical Care Innovation to Cardiovascular Medicine Through www.EndoVascular.Org, a Global, Multi-disciplinary Care 4Health News:Launch of New 'Independent Aging' Company Will Address the Needs of the Growing Senior Population 2Health News:Launch of New 'Independent Aging' Company Will Address the Needs of the Growing Senior Population 3Health News:ACS PressPac -- Dec. 10, 2008 2Health News:ACS PressPac -- Dec. 10, 2008 3Health News:ACS PressPac -- Dec. 10, 2008 4Health News:ACS PressPac -- Dec. 10, 2008 5Health News:ACS PressPac -- Dec. 10, 2008 6Health News:ACS PressPac -- Dec. 10, 2008 7Health News:Mental Health America Celebrates 100 Years of Mental Health Advocacy and Support 2Health News:Mental Health America Celebrates 100 Years of Mental Health Advocacy and Support 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... System is a panel mounted system that offers ... needs of the heath care professional using the ... available with a dual action lever that allows ... to an IV pole. Similarly, it features ...
Medicine Products: